CNBX Pharmaceuticals Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q3 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
CNBX Pharmaceuticals Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q3 2010 to Q4 2024.
  • CNBX Pharmaceuticals Inc. Retained Earnings (Accumulated Deficit) for the quarter ending November 30, 2024 was -$25M, a 2.26% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 -$25M -$551K -2.26% Nov 30, 2024 10-Q 2025-01-13
Q3 2024 -$25M -$695K -2.87% Aug 31, 2024 10-Q 2025-01-13
Q2 2024 -$24.9M -$1.21M -5.1% May 31, 2024 10-Q 2024-07-15
Q1 2024 -$24.8M -$1.23M -5.24% Feb 29, 2024 10-Q 2024-04-16
Q4 2023 -$24.4M -$3.53M -16.9% Nov 30, 2023 10-Q 2024-01-12
Q3 2023 -$24.3M -$3.71M -18.1% Aug 31, 2023 10-K 2024-11-29
Q2 2023 -$23.7M -$3.62M -18% May 31, 2023 10-Q 2023-07-14
Q1 2023 -$23.5M -$4.14M -21.4% Feb 28, 2023 10-Q 2023-04-14
Q4 2022 -$20.9M -$2.76M -15.2% Nov 30, 2022 10-Q 2023-01-13
Q3 2022 -$20.5M -$3.72M -22.1% Aug 31, 2022 10-K 2023-11-30
Q2 2022 -$20.1M -$3.92M -24.3% May 31, 2022 10-Q 2022-07-14
Q1 2022 -$19.4M -$4.57M -30.8% Feb 28, 2022 10-Q 2022-04-12
Q4 2021 -$18.1M -$3.86M -27% Nov 30, 2021 10-Q 2022-01-13
Q3 2021 -$16.8M -$3.19M -23.4% Aug 31, 2021 10-K 2022-11-30
Q2 2021 -$16.1M -$3.25M -25.2% May 31, 2021 10-Q 2021-07-14
Q1 2021 -$14.8M -$2.65M -21.7% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 -$14.3M -$2.98M -26.4% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 -$13.6M -$7.47M -121% Aug 31, 2020 10-K 2021-11-29
Q2 2020 -$12.9M -$8.13M -170% May 31, 2020 10-Q 2020-07-14
Q1 2020 -$12.2M -$7.95M -188% Feb 29, 2020 10-Q 2020-04-13
Q4 2019 -$11.3M -$3.35M -42.2% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 -$6.16M +$1.13M +15.5% Aug 31, 2019 10-K 2020-11-04
Q2 2019 -$4.77M +$1.79M +27.3% May 31, 2019 10-Q 2019-07-15
Q1 2019 -$4.22M +$1.47M +25.8% Feb 28, 2019 10-Q 2019-04-15
Q4 2018 -$7.95M -$3.9M -96% Nov 30, 2018 10-Q 2019-01-17
Q3 2018 -$7.3M -$3.78M -107% Aug 31, 2018 10-K 2019-11-29
Q2 2018 -$6.56M -$4.15M -172% May 31, 2018 10-Q 2018-07-16
Q1 2018 -$5.69M -$3.52M -162% Feb 28, 2018 10-Q 2018-04-05
Q4 2017 -$4.06M -$2.32M -134% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 -$3.52M -$1.93M -122% Aug 31, 2017 10-K 2018-11-29
Q2 2017 -$2.42M -$899K -59.2% May 31, 2017 10-Q 2017-07-17
Q1 2017 -$2.17M -$680K -45.6% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 -$1.73M -$399K -29.9% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 -$1.59M -$307K -24% Aug 31, 2016 10-K 2017-12-08
Q2 2016 -$1.52M -$444K -41.3% May 31, 2016 10-Q 2016-07-13
Q1 2016 -$1.49M -$571K -62% Feb 29, 2016 10-Q 2016-04-18
Q4 2015 -$1.33M -$469K -54.2% Nov 30, 2015 10-Q/A 2016-04-08
Q3 2015 -$1.28M -$541K -73.4% Aug 31, 2015 10-K 2016-12-13
Q2 2015 -$1.07M -$505K -88.7% May 31, 2015 10-Q/A 2015-11-17
Q1 2015 -$920K -$407K -79.3% Feb 28, 2015 10-Q/A 2015-11-17
Q4 2014 -$865K -$384K -79.9% Nov 30, 2014 10-Q/A 2015-11-17
Q3 2014 -$738K -$270K -57.7% Aug 31, 2014 10-K 2016-01-07
Q2 2014 -$569K -$133K -30.6% May 31, 2014 10-Q/A 2014-07-15
Q1 2014 -$513K -$82.2K -19.1% Feb 28, 2014 10-Q 2014-04-01
Q4 2013 -$481K -$54.6K -12.8% Nov 30, 2013 10-Q 2014-01-14
Q3 2013 -$468K -$56.4K -13.7% Aug 31, 2013 10-K/A 2015-10-23
Q2 2013 -$436K May 31, 2013 10-Q 2013-07-15
Q1 2013 -$431K -$9.33K -2.21% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 -$426K -$6.54K -1.56% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 -$411K -$1.65K -0.4% Aug 31, 2012 10-K 2013-11-29
Q1 2012 -$422K Feb 29, 2012 10-Q 2012-04-13
Q4 2011 -$420K Nov 30, 2011 10-Q 2012-01-13
Q3 2011 -$410K $0 0% Aug 31, 2011 10-K 2012-11-30
Q2 2011 -$426K May 31, 2011 10-Q 2012-07-06
Q3 2010 -$410K Aug 31, 2010 10-Q 2012-07-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.